首页 > 最新文献

Medicina-buenos Aires最新文献

英文 中文
[Neurofibromatosis: advances in diagnosis and treatment]. 神经纤维瘤病:诊断与治疗进展。
IF 0.6 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01
Paula Ivarola

Neurofibromatosis type 1 (NF1) is a genetically determined, autosomal dominant disease with complete penetrance and variable clinical expression. It is characterized by the presence of café-au-lait macules, ephelides, Lisch nodules, neurofibromas, plexiform neurofibromas and predisposition to tumours. From a neurological point of view, it can manifest with migraines, seizures, vasculopathy, learning disorders, etc. The current diagnostic criteria include genetic and new ophthalmological findings. Although, the extensive clinical and genetic heterogeneity of the disorder makes genotype-phenotype correlation difficult. Recent studies have revealed a limited number of genotype-phenotype correlations which have improved the understanding of this disease and have favored the development of precision treatments (MEK pathway inhibitors), improving quality of life of affected children. A multidisciplinary approach is crucial to provide appropriate care for these children. Early detection of neurological and oncological complications is important, to provide timely interventions to manage symptoms in a timely manner.

1型神经纤维瘤病(NF1)是一种遗传决定的常染色体显性疾病,具有完全外显率和可变的临床表现。它的特点是存在卡萨梅-au-lait斑疹、息肉、利施结节、神经纤维瘤、网状神经纤维瘤和易患肿瘤。从神经学的角度来看,它可以表现为偏头痛,癫痫发作,血管病变,学习障碍等。目前的诊断标准包括遗传学和新的眼科发现。尽管如此,该疾病广泛的临床和遗传异质性使得基因型-表型相关性变得困难。最近的研究揭示了有限数量的基因型-表型相关性,这些相关性提高了对这种疾病的理解,并有利于开发精确治疗(MEK通路抑制剂),改善受影响儿童的生活质量。多学科方法对于为这些儿童提供适当照顾至关重要。早期发现神经和肿瘤并发症很重要,可以及时提供干预措施,及时控制症状。
{"title":"[Neurofibromatosis: advances in diagnosis and treatment].","authors":"Paula Ivarola","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Neurofibromatosis type 1 (NF1) is a genetically determined, autosomal dominant disease with complete penetrance and variable clinical expression. It is characterized by the presence of café-au-lait macules, ephelides, Lisch nodules, neurofibromas, plexiform neurofibromas and predisposition to tumours. From a neurological point of view, it can manifest with migraines, seizures, vasculopathy, learning disorders, etc. The current diagnostic criteria include genetic and new ophthalmological findings. Although, the extensive clinical and genetic heterogeneity of the disorder makes genotype-phenotype correlation difficult. Recent studies have revealed a limited number of genotype-phenotype correlations which have improved the understanding of this disease and have favored the development of precision treatments (MEK pathway inhibitors), improving quality of life of affected children. A multidisciplinary approach is crucial to provide appropriate care for these children. Early detection of neurological and oncological complications is important, to provide timely interventions to manage symptoms in a timely manner.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"85 Suppl 4 ","pages":"83-87"},"PeriodicalIF":0.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145206694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Parasomnias in pediatrics]. [儿科的异梦症]。
IF 0.6 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01
Víctor A Gaona

Parasomnias, from the Greek "para" (around) and the Latin "somnus" (sleep), refer to manifestations that occur in relation to sleep: whether at the onset, during its course, or upon waking. They constitute up to a third of consultations. These events are striking and often bothersome, both for those who experience them and for those who observe them. They involve motor, cardiovascular, or other manifestations, generating fear and/or anxiety when witnessed. Some parasomnias show a familial pattern or are associated with neurodevelopmental disorders, appearing in relation to triggers such as febrile processes, medications, emotional disturbances, or respiratory disorders. This can lead to confusion with conditions like epilepsy, necessitating meticulous examination and clinical history-taking to ensure accurate diagnosis. The International Classification of Sleep Disorders (ICSD-3) by the American Academy of Sleep Medicine (AASM) classifies parasomnias into three categories: a) Parasomnias related to REM (rapid eye movement) sleep; b) Parasomnias related to non-REM sleep and c) Other specified or unspecified parasomnias. Given the impact of sleep problems on children's development, it is essential to be adequately prepared and informed to address these issues and prevent potential complications.

Parasomnias来自希腊语“para”(周围)和拉丁语“somnus”(睡眠),指的是与睡眠有关的表现:无论是在开始时,在过程中,还是在醒来时。它们占协商的三分之一。这些事件令人震惊,而且往往令人烦恼,无论是对经历它们的人还是对观察它们的人来说。它们包括运动、心血管或其他表现,当目睹时产生恐惧和/或焦虑。一些睡眠异常表现出家族性模式或与神经发育障碍有关,与发热过程、药物、情绪障碍或呼吸障碍等诱发因素有关。这可能导致与癫痫等疾病混淆,需要进行细致的检查和临床病史记录,以确保准确诊断。美国睡眠医学会(AASM)的《国际睡眠障碍分类》(ICSD-3)将睡眠异常分为三类:a)与REM(快速眼动)睡眠相关的睡眠异常;b)与非快速眼动睡眠相关的睡眠异常;c)其他特定或未指定的睡眠异常。鉴于睡眠问题对儿童发育的影响,有必要做好充分的准备和了解,以解决这些问题,防止潜在的并发症。
{"title":"[Parasomnias in pediatrics].","authors":"Víctor A Gaona","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Parasomnias, from the Greek \"para\" (around) and the Latin \"somnus\" (sleep), refer to manifestations that occur in relation to sleep: whether at the onset, during its course, or upon waking. They constitute up to a third of consultations. These events are striking and often bothersome, both for those who experience them and for those who observe them. They involve motor, cardiovascular, or other manifestations, generating fear and/or anxiety when witnessed. Some parasomnias show a familial pattern or are associated with neurodevelopmental disorders, appearing in relation to triggers such as febrile processes, medications, emotional disturbances, or respiratory disorders. This can lead to confusion with conditions like epilepsy, necessitating meticulous examination and clinical history-taking to ensure accurate diagnosis. The International Classification of Sleep Disorders (ICSD-3) by the American Academy of Sleep Medicine (AASM) classifies parasomnias into three categories: a) Parasomnias related to REM (rapid eye movement) sleep; b) Parasomnias related to non-REM sleep and c) Other specified or unspecified parasomnias. Given the impact of sleep problems on children's development, it is essential to be adequately prepared and informed to address these issues and prevent potential complications.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"85 Suppl 4 ","pages":"77-82"},"PeriodicalIF":0.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145206709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Skin manifestations in metabolic diseases]. [代谢性疾病的皮肤表现]。
IF 0.6 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01
Jaume Campistol, Katia Henostroza

Diagnosing a metabolic disease is not a simple task. There are more than 2000 metabolic diseases, 70% of which present with neurological manifestations. The signs and symptoms of these neurometabolic diseases are highly varied and range from purely neurological, biochemical, multisystemic, or simply cutaneous. Cutaneous manifestations in metabolic diseases appear in 10-12% as the initial sign or accompany other neurological or systemic manifestations. Identifying these cutaneous signs can assist the clinician in orienting suspicion, facilitating diagnosis, or identifying complications or treatment side effects. The main cutaneous manifestations in neurometabolic diseases can be grouped into vascular lesions, ichthyosis, papular and nodular skin lesions, pigmentation disorders, photosensitivity, skin laxity and hair involvement. In this article, we summarize the most common cutaneous signs in metabolic diseases, diagnostic guidance, and therapeutic options.

诊断代谢性疾病并不是一件简单的事情。有2000多种代谢性疾病,其中70%表现为神经症状。这些神经代谢性疾病的体征和症状是高度多样化的,范围从纯粹的神经学、生物化学、多系统或单纯的皮肤。10-12%的代谢性疾病的皮肤表现为首发症状或伴随其他神经或全身表现。识别这些皮肤征象可以帮助临床医生确定怀疑,促进诊断,或识别并发症或治疗副作用。神经代谢性疾病的主要皮肤表现可分为血管病变、鱼鳞病、丘疹和结节性皮肤病变、色素沉着障碍、光敏性、皮肤松弛和头发受累。在本文中,我们总结了代谢性疾病中最常见的皮肤体征,诊断指导和治疗选择。
{"title":"[Skin manifestations in metabolic diseases].","authors":"Jaume Campistol, Katia Henostroza","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Diagnosing a metabolic disease is not a simple task. There are more than 2000 metabolic diseases, 70% of which present with neurological manifestations. The signs and symptoms of these neurometabolic diseases are highly varied and range from purely neurological, biochemical, multisystemic, or simply cutaneous. Cutaneous manifestations in metabolic diseases appear in 10-12% as the initial sign or accompany other neurological or systemic manifestations. Identifying these cutaneous signs can assist the clinician in orienting suspicion, facilitating diagnosis, or identifying complications or treatment side effects. The main cutaneous manifestations in neurometabolic diseases can be grouped into vascular lesions, ichthyosis, papular and nodular skin lesions, pigmentation disorders, photosensitivity, skin laxity and hair involvement. In this article, we summarize the most common cutaneous signs in metabolic diseases, diagnostic guidance, and therapeutic options.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"85 Suppl 4 ","pages":"88-94"},"PeriodicalIF":0.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145206720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Intellectual giftedness: Implications and diagnostic approach]. [智力天赋:含义和诊断方法]。
IF 0.6 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01
María Teresa Acosta-Puentes, Beatriz Romo-Pardo

Intellectual giftedness is defined as the manifestation in an individual of exceptional cognitive abilities in various areas of knowledge, skills, or competencies, compared to the average performance standards observed in the general population. Parents, teachers, and neurobiologists face complex questions for which there are still few conclusive answers. It presents a critical analysis of current diagnostic processes, challenges, and limitations. It also discusses biological factors involved, such as genetics, brain function, and development, as well as the influence of the environment on the expression and enhancement of these abilities. Finally, practical recommendations are offered to professionals, families, and educators to foster environments that promote harmonic development for those exceptional children and opportunities for the development of their full potential for all children.

智力天赋被定义为与一般人群的平均表现标准相比,个人在各个知识、技能或能力领域具有特殊认知能力的表现。家长、老师和神经生物学家都面临着一些复杂的问题,而对于这些问题,目前还没有确切的答案。它提出了当前诊断过程,挑战和局限性的关键分析。它还讨论了涉及的生物因素,如遗传、脑功能和发育,以及环境对这些能力的表达和增强的影响。最后,为专业人士、家庭和教育工作者提供了切实可行的建议,以营造促进特殊儿童和谐发展的环境,并为所有儿童提供充分发展潜力的机会。
{"title":"[Intellectual giftedness: Implications and diagnostic approach].","authors":"María Teresa Acosta-Puentes, Beatriz Romo-Pardo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Intellectual giftedness is defined as the manifestation in an individual of exceptional cognitive abilities in various areas of knowledge, skills, or competencies, compared to the average performance standards observed in the general population. Parents, teachers, and neurobiologists face complex questions for which there are still few conclusive answers. It presents a critical analysis of current diagnostic processes, challenges, and limitations. It also discusses biological factors involved, such as genetics, brain function, and development, as well as the influence of the environment on the expression and enhancement of these abilities. Finally, practical recommendations are offered to professionals, families, and educators to foster environments that promote harmonic development for those exceptional children and opportunities for the development of their full potential for all children.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"85 Suppl 4 ","pages":"22-27"},"PeriodicalIF":0.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145206566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Acquired brain injury in pediatrics: a review on cognitive rehabilitation techniques]. [儿科获得性脑损伤:认知康复技术综述]。
IF 0.6 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01
Genesis N Ayala-Lopez, Taha F Khan, Alcy R Torres

Acquired brain damage, comprising traumatic and nontraumatic brain injuries, is a major public health concern with far-reaching effects on prognosis and continued disability. This review aims to explore the types of acquired brain damage and cognitive rehabilitation techniques, and the role of cognitive rehabilitation in aiding recovery in pediatric populations. This further highlights the current gaps in research and future directions.

获得性脑损伤包括创伤性和非创伤性脑损伤,是一个重大的公共卫生问题,对预后和持续残疾具有深远影响。本文旨在探讨儿童获得性脑损伤的类型和认知康复技术,以及认知康复在帮助儿童康复中的作用。这进一步凸显了目前研究的差距和未来的方向。
{"title":"[Acquired brain injury in pediatrics: a review on cognitive rehabilitation techniques].","authors":"Genesis N Ayala-Lopez, Taha F Khan, Alcy R Torres","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Acquired brain damage, comprising traumatic and nontraumatic brain injuries, is a major public health concern with far-reaching effects on prognosis and continued disability. This review aims to explore the types of acquired brain damage and cognitive rehabilitation techniques, and the role of cognitive rehabilitation in aiding recovery in pediatric populations. This further highlights the current gaps in research and future directions.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"85 Suppl 4 ","pages":"28-33"},"PeriodicalIF":0.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145206403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Immune-mediated polyneuropathies]. 免疫介导性多神经病。
IF 0.6 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01
Silvia Cerezo, Jesica Expósito, Laura Carrera, Daniel Natera, Andrés Nascimento, Carlos Ortez

The Guillain-Barré syndrome (GBS) represents a group of immune-mediated peripheral polyneuropathies, which are the most common cause of acute flaccid paralysis in clinical practice. Its most prevalent form is acute inflammatory demyelinating polyneuropathy (AIDP), though multiple variants are also recognized, such as axonal neuropathies (AMAN, AMSAN) and MillerFisher syndrome. Diagnosis remains primarily clinical, supported by findings in cerebrospinal fluid analysis, neurophysiological studies, and, in certain cases, specific serology. Early detection is crucial to prevent potentially fatal complications such as respiratory failure or severe dysautonomia. This article provides an updated review of the diagnostic and therapeutic approaches to GBS, emphasizing its pathophysiology, clinical manifestations, first-line therapeutic strategies, and emerging variants treatable with targeted immunotherapy.

吉兰-巴罗综合征(GBS)是一组免疫介导的周围多神经病变,在临床实践中是急性弛缓性麻痹的最常见原因。其最常见的形式是急性炎症性脱髓鞘性多神经病变(AIDP),尽管也有多种变体,如轴突神经病(AMAN, AMSAN)和米勒-费舍尔综合征。诊断仍然主要是临床诊断,由脑脊液分析、神经生理学研究以及在某些情况下的特定血清学结果支持。早期发现对于预防潜在的致命并发症(如呼吸衰竭或严重的自主神经异常)至关重要。本文综述了GBS的最新诊断和治疗方法,重点介绍了GBS的病理生理、临床表现、一线治疗策略以及可通过靶向免疫治疗的新变体。
{"title":"[Immune-mediated polyneuropathies].","authors":"Silvia Cerezo, Jesica Expósito, Laura Carrera, Daniel Natera, Andrés Nascimento, Carlos Ortez","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The Guillain-Barré syndrome (GBS) represents a group of immune-mediated peripheral polyneuropathies, which are the most common cause of acute flaccid paralysis in clinical practice. Its most prevalent form is acute inflammatory demyelinating polyneuropathy (AIDP), though multiple variants are also recognized, such as axonal neuropathies (AMAN, AMSAN) and MillerFisher syndrome. Diagnosis remains primarily clinical, supported by findings in cerebrospinal fluid analysis, neurophysiological studies, and, in certain cases, specific serology. Early detection is crucial to prevent potentially fatal complications such as respiratory failure or severe dysautonomia. This article provides an updated review of the diagnostic and therapeutic approaches to GBS, emphasizing its pathophysiology, clinical manifestations, first-line therapeutic strategies, and emerging variants treatable with targeted immunotherapy.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"85 Suppl 4 ","pages":"41-46"},"PeriodicalIF":0.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145206371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Skin and soft tissue infections management guideline]. [皮肤和软组织感染管理指南]。
IF 0.6 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-05-01
Lautaro De Vedia, Claudia Rodríguez, Marta Torres, Nicolás Zujlevic, Alicia Puscama, Liliana Clara, Andrés Sandor, Corina Nemirovsky, Eugenia Di Líbero, Analía Mykietiuk, Viviana Leiro, Bernardo Kantor, Patricia Fernández Pardal, María Elena Peña, Ivana Pedraza Salazar, Marcelo Zylberman, Adriana Romani, Claudia Barberis, Lucila Bonesi, Luciana Di Cugno, Flavia Amalfa, Ana Matilde Israel, Eleonora Cunto, Marco Flores Montes, Mónica Moyano, Juan Manuel Poggio, Alejandra Margarí, Flavio Rotryng, Fernanda Barberis, Natalia Pujato, Gladys Ferrucci, María Marta Greco, Natalia Bello

Skin and soft tissue infections (SSTIs) are extremely common, and while the vast majority are mild, they can occasionally lead to serious local and systemic complications. Therefore, early recognition and appropriate medical and surgical management are of primary importance. In 2009, the Argentine Society of Infectious Diseases (SADI), along with other scientific societies, published its latest recommendations. This Guide was developed by specialists from the Argentine Society of Infectious Diseases (SADI) and discussed in a plenary meeting with the participation of representatives from six other Scientific Societies: Argentine Society of Dermatology, Argentine Association of Surgery, Argentine Society of Medicine, Argentine Association of Clinical Microbiology, Buenos Aires Society of Internal Medicine, and Argentine Society of Intensive Care, based on their experience in this subject. Each chapter contains recommendations based on scientific evidence and expert opinion, including useful diagnostic tools, with special emphasis on clinical assessment and differential diagnoses, and antimicrobial therapy, with attention to the responsible use of antibiotics.

皮肤和软组织感染(SSTIs)是非常常见的,虽然绝大多数是轻微的,但它们偶尔会导致严重的局部和全身并发症。因此,早期识别和适当的医疗和外科治疗是至关重要的。2009年,阿根廷传染病学会(SADI)与其他科学学会一起发表了其最新建议。该指南由阿根廷传染病学会的专家制定,并在一次全体会议上进行了讨论,其他六个科学学会的代表参加了会议:阿根廷皮肤病学会、阿根廷外科学会、阿根廷医学学会、阿根廷临床微生物学会、布宜诺斯艾利斯内科学会和阿根廷重症监护学会,根据他们在这一主题方面的经验。每一章都包含基于科学证据和专家意见的建议,包括有用的诊断工具,特别强调临床评估和鉴别诊断,以及抗微生物治疗,并注意负责任地使用抗生素。
{"title":"[Skin and soft tissue infections management guideline].","authors":"Lautaro De Vedia, Claudia Rodríguez, Marta Torres, Nicolás Zujlevic, Alicia Puscama, Liliana Clara, Andrés Sandor, Corina Nemirovsky, Eugenia Di Líbero, Analía Mykietiuk, Viviana Leiro, Bernardo Kantor, Patricia Fernández Pardal, María Elena Peña, Ivana Pedraza Salazar, Marcelo Zylberman, Adriana Romani, Claudia Barberis, Lucila Bonesi, Luciana Di Cugno, Flavia Amalfa, Ana Matilde Israel, Eleonora Cunto, Marco Flores Montes, Mónica Moyano, Juan Manuel Poggio, Alejandra Margarí, Flavio Rotryng, Fernanda Barberis, Natalia Pujato, Gladys Ferrucci, María Marta Greco, Natalia Bello","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Skin and soft tissue infections (SSTIs) are extremely common, and while the vast majority are mild, they can occasionally lead to serious local and systemic complications. Therefore, early recognition and appropriate medical and surgical management are of primary importance. In 2009, the Argentine Society of Infectious Diseases (SADI), along with other scientific societies, published its latest recommendations. This Guide was developed by specialists from the Argentine Society of Infectious Diseases (SADI) and discussed in a plenary meeting with the participation of representatives from six other Scientific Societies: Argentine Society of Dermatology, Argentine Association of Surgery, Argentine Society of Medicine, Argentine Association of Clinical Microbiology, Buenos Aires Society of Internal Medicine, and Argentine Society of Intensive Care, based on their experience in this subject. Each chapter contains recommendations based on scientific evidence and expert opinion, including useful diagnostic tools, with special emphasis on clinical assessment and differential diagnoses, and antimicrobial therapy, with attention to the responsible use of antibiotics.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"85 Suppl 3 ","pages":"14-76"},"PeriodicalIF":0.6,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144160115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Parenteral anticoagulants. Update on use and monitoring of heparin and its derivatives]. (注射用药物的抗凝血剂。肝素及其衍生物使用和监测的最新情况[j]。
IF 0.6 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-01
José M Ceresetto, Cristina Duboscq, Alejandra Scazziota, Claudio Rosa, Marta Martinuzzo, Soledad Molnar, Fernando Chuliber, Patricia Casais, Jorge Korin

Heparin and its different formulations and derivatives, the first and second generation low molecular weight heparins and pentasaccharides, are indirect parenteral anticoagulants that, with limitations and difficulties, continue to have a privileged place in the modern therapeutic arsenal. Even after many years of use, their unique properties make them the best possible anticoagulant in certain scenarios, such as in pregnancy, end stage renal insufficiency or patients that need a quick and reversible anticoagulation. They are also the anticoagulant of choice when it is important to inhibit clots related to external surfaces where the activation of the intrinsic coagulation pathway is especially relevant. Examples of the importance of these compounds are their nowadays first place recommendation in certain thrombosis like in cancer, hemodialysis, or extracorporeal cardiac devices. Also, in patients with venous thromboembolism and hemodynamic instability, high risk of bleeding or in the acute coronary syndrome, heparins are today the preferred anticoagulant. However, the management of heparins is complex and, in some cases, requires frequent laboratory measurements for monitoring. They can eventually cause severe adverse events, such as life-threatening bleeding episodes or thrombosis associated with immune activation of platelets. Understanding the characteristics of these anticoagulants, their use and correct monitoring will allow us to use the different heparins safely. The role of the haemostasis laboratory is essential to adjust the dose of unfractionated heparin, which have proven to be difficult to manage for the general practitioner. In this document we actualize the laboratory and clinical management of heparins and related drugs in the modern anticoagulation era.

肝素及其不同的配方和衍生物,第一代和第二代低分子量肝素和五糖,是间接肠外抗凝剂,具有局限性和困难,在现代治疗武器库中继续占有特殊地位。即使经过多年的使用,其独特的特性使其成为某些情况下最好的抗凝剂,如怀孕、终末期肾功能不全或需要快速和可逆抗凝的患者。当重要的是抑制与外部表面相关的凝块时,它们也是首选的抗凝剂,其中内在凝血途径的激活尤其相关。这些化合物的重要性的例子是它们现在在某些血栓形成,如癌症,血液透析或体外心脏装置的首选推荐。此外,对于静脉血栓栓塞和血流动力学不稳定、出血风险高或急性冠状动脉综合征的患者,肝素是目前首选的抗凝剂。然而,肝素的管理是复杂的,在某些情况下,需要经常进行实验室测量监测。它们最终可能导致严重的不良事件,如危及生命的出血发作或与血小板免疫激活相关的血栓形成。了解这些抗凝血剂的特性、使用和正确监测将使我们安全地使用不同的肝素。止血实验室的作用是必不可少的,以调整未分离肝素的剂量,这已被证明是难以管理的全科医生。本文介绍了现代抗凝时代肝素及相关药物的实验室和临床管理。
{"title":"[Parenteral anticoagulants. Update on use and monitoring of heparin and its derivatives].","authors":"José M Ceresetto, Cristina Duboscq, Alejandra Scazziota, Claudio Rosa, Marta Martinuzzo, Soledad Molnar, Fernando Chuliber, Patricia Casais, Jorge Korin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Heparin and its different formulations and derivatives, the first and second generation low molecular weight heparins and pentasaccharides, are indirect parenteral anticoagulants that, with limitations and difficulties, continue to have a privileged place in the modern therapeutic arsenal. Even after many years of use, their unique properties make them the best possible anticoagulant in certain scenarios, such as in pregnancy, end stage renal insufficiency or patients that need a quick and reversible anticoagulation. They are also the anticoagulant of choice when it is important to inhibit clots related to external surfaces where the activation of the intrinsic coagulation pathway is especially relevant. Examples of the importance of these compounds are their nowadays first place recommendation in certain thrombosis like in cancer, hemodialysis, or extracorporeal cardiac devices. Also, in patients with venous thromboembolism and hemodynamic instability, high risk of bleeding or in the acute coronary syndrome, heparins are today the preferred anticoagulant. However, the management of heparins is complex and, in some cases, requires frequent laboratory measurements for monitoring. They can eventually cause severe adverse events, such as life-threatening bleeding episodes or thrombosis associated with immune activation of platelets. Understanding the characteristics of these anticoagulants, their use and correct monitoring will allow us to use the different heparins safely. The role of the haemostasis laboratory is essential to adjust the dose of unfractionated heparin, which have proven to be difficult to manage for the general practitioner. In this document we actualize the laboratory and clinical management of heparins and related drugs in the modern anticoagulation era.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"85 Suppl 2 ","pages":"1-45"},"PeriodicalIF":0.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144021133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Verbal irony and high intellectual capacity: comparative approach (7-9 years)]. 言语反讽与高智力:比较方法(7-9岁)。
IF 0.6 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01
Sylvia Sastre-Riba, Lourdes Viana-Sáenz, Diego Lería Ugarte

Introduction: The neurobiological potentiality of cognitive resources in High Intellectual Ability (HIA) involves complex cognition and representation of the world. This is related to language and figurative language. Competence in figurative language and its forms, such as verbal irony, is an understudied aspect of High Intellectual Ability that could provide a broader understanding of the abilities that constitute it, compared to the development of typical intelligence. The aim of this study was to investigate how children with HIA, aged 7-9 years, understand verbal irony and to compare their competence with typical children of the same age.

Methods: A univariate analysis of variance was performed on responses to the VIrQ questionnaire from a sample of n=62 schoolchildren with HIA and an agematched control group of typical schoolchildren (n=62).

Results: Show the complexity of verbal irony comprehension in participants with HIA at the age of 7-9 years compared to typical schoolchildren.

Discussion: We conclude and discuss comparing the components of irony that were most easily understood in each group, as well as those that were most difficult, suggesting the relevance of this area of study for better understanding the functioning of high intellectual ability, the relationship of verbal irony to other higher-level cognitive processes, and its possible role as complementary information in differential cognitive assessment.

高智力(HIA)认知资源的神经生物学潜能涉及复杂的认知和对世界的表征。这与语言和比喻语言有关。比喻语言及其形式的能力,如言语反讽,是高智力能力的一个未被充分研究的方面,与典型智力的发展相比,它可以提供对构成它的能力的更广泛理解。本研究的目的是调查7-9岁的HIA儿童如何理解言语讽刺,并将他们的能力与同龄的典型儿童进行比较。方法:采用单因素方差分析方法,对62名HIA小学生和62名年龄匹配的典型小学生进行问卷调查。结果:在7-9岁儿童中,HIA患者的反语理解复杂性与正常学龄儿童相比有所提高。讨论:我们总结并讨论比较各组中最容易理解的反讽成分和最难理解的反讽成分,表明这一研究领域与更好地理解高智力的功能、言语反讽与其他高级认知过程的关系以及它在差异认知评估中作为补充信息的可能作用的相关性。
{"title":"[Verbal irony and high intellectual capacity: comparative approach (7-9 years)].","authors":"Sylvia Sastre-Riba, Lourdes Viana-Sáenz, Diego Lería Ugarte","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The neurobiological potentiality of cognitive resources in High Intellectual Ability (HIA) involves complex cognition and representation of the world. This is related to language and figurative language. Competence in figurative language and its forms, such as verbal irony, is an understudied aspect of High Intellectual Ability that could provide a broader understanding of the abilities that constitute it, compared to the development of typical intelligence. The aim of this study was to investigate how children with HIA, aged 7-9 years, understand verbal irony and to compare their competence with typical children of the same age.</p><p><strong>Methods: </strong>A univariate analysis of variance was performed on responses to the VIrQ questionnaire from a sample of n=62 schoolchildren with HIA and an agematched control group of typical schoolchildren (n=62).</p><p><strong>Results: </strong>Show the complexity of verbal irony comprehension in participants with HIA at the age of 7-9 years compared to typical schoolchildren.</p><p><strong>Discussion: </strong>We conclude and discuss comparing the components of irony that were most easily understood in each group, as well as those that were most difficult, suggesting the relevance of this area of study for better understanding the functioning of high intellectual ability, the relationship of verbal irony to other higher-level cognitive processes, and its possible role as complementary information in differential cognitive assessment.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"85 Suppl 1 ","pages":"69-75"},"PeriodicalIF":0.6,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143527920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A multicomponential dyslexia intervention program]. [多组分阅读障碍干预计划]。
IF 0.6 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01
Manuel Soriano-Ferrer, Ana María Casino García, Lucía I Llinares-Insa, Manuel R Morte-Soriano

Introduction: In recent decades, different studies have shown the effectiveness of intervention programs that incorporate multiple components to optimize the results of the interventions. However, the analysis of the effectiveness of multicomponent programs in Spanish is relatively scarce. Therefore, the main objective of the present study was to analyze the effectiveness of a multicomponent program (i.e., phonological-based training with visual letter support, Reading fluency training, and motivational strategies) on Reading skills and Reading motivation in Spanish children with dyslexia.

Materials and methods: Twenty-four children with dyslexia between 9 and 12 years of age participated. Support teachers individually applied the multicomponent program for 20 weeks at a rate of three weekly sessions of about 40-50 minutes. Different measures of word, pseudo-word, text and comprehension reading, as well as Reading motivation indicators were taken.

Results: The results of the comparison between pretreatment and post-treatment phase scores indicate that students with dyslexia increased their performance on Reading measures (e.g., word-reading efficiency, pseudowords, text reading speed and accuracy index, reading comprehension), as well as on reading motivation measures (e.g., reading self-concept, reading value, and reading engagement).

Discussion: Results are discussed with respect to effective interventions for students with dyslexia. Reflections on the limitations of the study provide a basis for recommending future lines of research.

导言:近几十年来,不同的研究表明,包含多个组成部分以优化干预效果的干预计划非常有效。然而,在西班牙语中对多成分方案的有效性分析却相对较少。因此,本研究的主要目的是分析多成分项目(即基于语音的视觉字母支持训练、阅读流利性训练和激励策略)对西班牙诵读困难儿童阅读技能和阅读动机的有效性:24 名 9 至 12 岁有阅读障碍的儿童参加了研究。辅助教师在 20 周内单独实施多成分计划,每周三次,每次约 40-50 分钟。对单词、伪单词、文本和理解性阅读以及阅读动机指标进行了不同的测量:结果:治疗前和治疗后阶段得分的比较结果表明,有阅读障碍的学生在阅读测量(如单词阅读效率、假词、文本阅读速度和准确性指数、阅读理解)以及阅读动机测量(如阅读自我概念、阅读价值和阅读参与)方面的成绩均有所提高:讨论:本研究就针对阅读障碍学生的有效干预措施对结果进行了讨论。对研究局限性的反思为建议未来的研究方向提供了依据。
{"title":"[A multicomponential dyslexia intervention program].","authors":"Manuel Soriano-Ferrer, Ana María Casino García, Lucía I Llinares-Insa, Manuel R Morte-Soriano","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>In recent decades, different studies have shown the effectiveness of intervention programs that incorporate multiple components to optimize the results of the interventions. However, the analysis of the effectiveness of multicomponent programs in Spanish is relatively scarce. Therefore, the main objective of the present study was to analyze the effectiveness of a multicomponent program (i.e., phonological-based training with visual letter support, Reading fluency training, and motivational strategies) on Reading skills and Reading motivation in Spanish children with dyslexia.</p><p><strong>Materials and methods: </strong>Twenty-four children with dyslexia between 9 and 12 years of age participated. Support teachers individually applied the multicomponent program for 20 weeks at a rate of three weekly sessions of about 40-50 minutes. Different measures of word, pseudo-word, text and comprehension reading, as well as Reading motivation indicators were taken.</p><p><strong>Results: </strong>The results of the comparison between pretreatment and post-treatment phase scores indicate that students with dyslexia increased their performance on Reading measures (e.g., word-reading efficiency, pseudowords, text reading speed and accuracy index, reading comprehension), as well as on reading motivation measures (e.g., reading self-concept, reading value, and reading engagement).</p><p><strong>Discussion: </strong>Results are discussed with respect to effective interventions for students with dyslexia. Reflections on the limitations of the study provide a basis for recommending future lines of research.</p>","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"85 Suppl 1 ","pages":"76-81"},"PeriodicalIF":0.6,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143527884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medicina-buenos Aires
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1